Showing 21 - 33 results of 33 for search 'Ferrata Storti Foundation', query time: 0.03s Refine Results
  1. 21
    40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies

    40 is the new 50: reducing the need for platelet transfusions prior to lumbar puncture in adults with hematologic malignancies by Kristen Corrao, Adrian Umpierrez, Angela Treml, Aniko Szabo, Laura Michaelis, Lyndsey Runaas, Guru Subramanian Guru Murthy, Sameem Abedin, Karen Carlson, Lisa Baumann Kreuziger, Ehab Atallah

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Comprehensive characterization of platelet function in dogs with hyperadrenocorticism

    Comprehensive characterization of platelet function in dogs with hyperadrenocorticism by Sanggu Kim, Dohee Lee, Preeti Kumari Chaudhary, Hakhyun Kim, Byeong-Teck Kang, Soochong Kim

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on “Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism” and on “The different faces of thrombotic thrombocytopenic purpura”

    More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on “Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible un... by Flora Peyvandi

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 24
    Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma

    Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma by Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 25
    The origins of the definition of complete remission in acute myeloid leukemia

    The origins of the definition of complete remission in acute myeloid leukemia by Mark R. Litzow

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 26
    Acute promyelocytic leukemia with <i>TTMV::RARA</i> fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment

    Acute promyelocytic leukemia with <i>TTMV::RARA</i> fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment by Qingyu Xu, Yebo Peng, Shu Sun, Yanru Zhang, Ting Shi, Xiaohong Kuang, Yin Wu, Hong-Hu Zhu

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 27
    The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data

    The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world st... by Matthew Schwede, Gladys Rodriguez, Vanessa E. Kennedy, Solomon Henry, Douglas Wood, Gabriel N. Mannis, Ravindra Majeti, Jonathan H. Chen, Eran Bendavid, Tian Yi Zhang

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 28
    Response to Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies

    Response to Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving C... by Pierre Peterlin, Maxime Jullien

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 29
    Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism

    Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism by Maria I. Zervou, George N. Goulielmos

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 30
    Nontuberculous mycobacterial infections following teclistamab in multiple myeloma

    Nontuberculous mycobacterial infections following teclistamab in multiple myeloma by Matthew Ho, Luca Paruzzo, Janna Minehart, Teja Voruganti, Pooja Devi, Dan T. Vogl, Adam D. Cohen, Alfred L. Garfall, Adam J. Waxman, Shivani Kapur, Edward A. Stadtmauer, Sandra Susanibar Adaniya, Sarah Longworth

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 31
    Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts

    Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts by SooHa Kim, Jumpei Teramachi, Masahiro Hiasa, Ryota Amachi, Ariunzaya Bat-Erdene, Asuka Oda, Hirofumi Tenshin, Mariko Tanaka, Motosumi Nakagawa, Aiko Seki, Yoshihiko Sawa, Ken-ichi Matsuoka, Eiji Tanaka, Takeshi Harada, Tatsuya Tominaga, Masahiro Abe

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 32
    Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation

    Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation by Eva N. Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, Varun Iyengar, Brian J. Carney, Ann Hoeben, Berna C. Özdemir, Rosana D. Cordova Serrano, Kristen M. Sanfilippo, Shira Rozenblatt, Ludo F.M. Beenen, Shlomit Yust-Katz, Erez Halperin, Ariela Arad, Aharon Lubetsky, Marc Carrier, Benjamin Massat, Harry R. Büller, Galia Spectre, Jeffrey I. Zwicker, Avi Leader, ABC Study Group

    Published 2025-02-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 33
    Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia

    Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia by Carlos Jiménez-Vicente, Iago Arribas, Helena Pomares, Guillermo Ramil, Sandra Castaño-Diez, Amanda Isabel Pérez-Valencia, Antonella Luciana Sturla, Mònica López-Guerra, Alexandra Martinez-Roca, Inés Zugasti, Francesca Guijarro, Albert Cortés-Bullich, Beatriz Merchán, Ana Triguero, Inés Monge, Albert Tuca, Guadalupe Oñate, Ana Garrido, Jorge Sierra, Montserrat Arnan, Jordi Esteve, Marina Díaz-Beyá, Spanish CETLAM Group

    Published 2025-01-01
    “…Ferrata Storti Foundation…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: